BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 16407327)

  • 1. APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells.
    Bogerd HP; Wiegand HL; Doehle BP; Lueders KK; Cullen BR
    Nucleic Acids Res; 2006; 34(1):89-95. PubMed ID: 16407327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOBEC3 proteins inhibit LINE-1 retrotransposition in the absence of ORF1p binding.
    Lovsin N; Peterlin BM
    Ann N Y Acad Sci; 2009 Oct; 1178():268-75. PubMed ID: 19845642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.
    Esnault C; Heidmann O; Delebecque F; Dewannieux M; Ribet D; Hance AJ; Heidmann T; Schwartz O
    Nature; 2005 Jan; 433(7024):430-3. PubMed ID: 15674295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.
    Buisson R; Lawrence MS; Benes CH; Zou L
    Cancer Res; 2017 Sep; 77(17):4567-4578. PubMed ID: 28698210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases.
    Dutko JA; Schäfer A; Kenny AE; Cullen BR; Curcio MJ
    Curr Biol; 2005 Apr; 15(7):661-6. PubMed ID: 15823539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.
    Bogerd HP; Wiegand HL; Doehle BP; Cullen BR
    Virology; 2007 Aug; 364(2):486-93. PubMed ID: 17434555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif.
    Doehle BP; Schäfer A; Cullen BR
    Virology; 2005 Sep; 339(2):281-8. PubMed ID: 15993456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOBEC3 proteins inhibit human LINE-1 retrotransposition.
    Muckenfuss H; Hamdorf M; Held U; Perković M; Löwer J; Cichutek K; Flory E; Schumann GG; Münk C
    J Biol Chem; 2006 Aug; 281(31):22161-22172. PubMed ID: 16735504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of autonomous IAP LTR retrotransposons mobile in mammalian cells.
    Dewannieux M; Dupressoir A; Harper F; Pierron G; Heidmann T
    Nat Genet; 2004 May; 36(5):534-9. PubMed ID: 15107856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.
    Warren CJ; Westrich JA; Doorslaer KV; Pyeon D
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28825669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses.
    Esnault C; Millet J; Schwartz O; Heidmann T
    Nucleic Acids Res; 2006; 34(5):1522-31. PubMed ID: 16537839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons.
    Ikeda T; Abd El Galil KH; Tokunaga K; Maeda K; Sata T; Sakaguchi N; Heidmann T; Koito A
    Nucleic Acids Res; 2011 Jul; 39(13):5538-54. PubMed ID: 21398638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins.
    Wiegand HL; Cullen BR
    J Virol; 2007 Dec; 81(24):13694-9. PubMed ID: 17913830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism.
    Stenglein MD; Harris RS
    J Biol Chem; 2006 Jun; 281(25):16837-16841. PubMed ID: 16648136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.
    Suspène R; Guétard D; Henry M; Sommer P; Wain-Hobson S; Vartanian JP
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8321-6. PubMed ID: 15919829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human APOBEC3G incorporation into murine leukemia virus particles.
    Kremer M; Bittner A; Schnierle BS
    Virology; 2005 Jun; 337(1):175-82. PubMed ID: 15914230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring APOBEC3A protein levels in human cancer cells.
    Dananberg A; Maciejowski J
    Methods Cell Biol; 2024; 182():313-327. PubMed ID: 38359985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes.
    Sanchez A; Ortega P; Sakhtemani R; Manjunath L; Oh S; Bournique E; Becker A; Kim K; Durfee C; Temiz NA; Chen XS; Harris RS; Lawrence MS; Buisson R
    Nat Commun; 2024 Mar; 15(1):2370. PubMed ID: 38499542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication.
    Hoopes JI; Cortez LM; Mertz TM; Malc EP; Mieczkowski PA; Roberts SA
    Cell Rep; 2016 Feb; 14(6):1273-1282. PubMed ID: 26832400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The betaretrovirus Mason-Pfizer monkey virus selectively excludes simian APOBEC3G from virion particles.
    Doehle BP; Bogerd HP; Wiegand HL; Jouvenet N; Bieniasz PD; Hunter E; Cullen BR
    J Virol; 2006 Dec; 80(24):12102-8. PubMed ID: 17035335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.